McClain v. AstraZeneca Pharmaceuticals LP et al

Filing 7

CONDITIONAL TRANSFER ORDER (CTO -5), TRANSFERRING CASE to the District of New Jersey. (farS, COURT STAFF) (Filed on 10/16/2017)

UNITED STATES JUDICIAL PANEL
on
MULTIDISTRICT LITIGATION

IN RE: PROTON-PUMP INHIBITOR
PRODUCTS LIABILITY LITIGATION (NO. II)

MDL No. 2789

(SEE ATTACHED SCHEDULE)

CONDITIONAL TRANSFER ORDER (CTO -5)

On August 2, 2017, the Panel transferred 100 civil action(s) to the United States District Court for
the District of New Jersey for coordinated or consolidated pretrial proceedings pursuant to 28 U.S.C.
§ 1407. See _F.Supp.3d_ (J.P.M.L. 2017). Since that time, 31 additional action(s) have been
transferred to the District of New Jersey. With the consent of that court, all such actions have been
assigned to the Honorable Claire C. Cecchi.
It appears that the action(s) on this conditional transfer order involve questions of fact that are
common to the actions previously transferred to the District of New Jersey and assigned to Judge
Cecchi.
Pursuant to Rule 7.1 of the Rules of Procedure of the United States Judicial Panel on Multidistrict
Litigation, the action(s) on the attached schedule are transferred under 28 U.S.C. § 1407 to the
District of New Jersey for the reasons stated in the order of August 2, 2017, and, with the consent of
that court, assigned to the Honorable Claire C. Cecchi.
This order does not become effective until it is filed in the Office of the Clerk of the United States
District Court for the District of New Jersey. The transmittal of this order to said Clerk shall be
stayed 7 days from the entry thereof. If any party files a notice of opposition with the Clerk of the
Panel within this 7—day period, the stay will be continued until further order of the Panel.

Inasmuch as no objection is
pending at this time, the

FOR THE PANEL:

Oct 12, 2017
CLERKS OFFICE
UNITED STATES
JUDICIAL PANEL ON
MULTIDISTRICT LITIGATION

I HEREBY CERTIFY ti t th Li
foregoing is a true and correct cocy &
the original on file in my office.
ATTEST
WILLIAM T. WALSH, Clerk
niedSsctcourt

Jeffery N. Lüthi

IN RE: PROTON-PUMP INHIBITOR
PRODUCTS LIABILITY LITIGATION (NO. II)

SCHEDULE CTO-5

DIST

DIV.

C.A.NO.

-

MDL No. 2789

TAG-ALONG ACTIONS

CASE CAPTION

CALIFORNIA NORTHERN
CAN

3

17—05625

McClain v. AstraZeneca Pharmaceuticals LP et a!

17—05776

Crawford v. Astrazeneca Pharmaceuticals LP

NEW YORK EASTERN
NYE

2